Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The immunopathogenesis and immunotherapy of cutaneous T cell lymphoma: Current and future approaches
David M. Weiner, Joseph S. Durgin, Maria Wysocka, et al.
Journal of the American Academy of Dermatology (2020) Vol. 84, Iss. 3, pp. 597-604
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue
Laura Connelly‐Smith, Caroline R. Alquist, Nicole A. Aqui, et al.
Journal of Clinical Apheresis (2023) Vol. 38, Iss. 2, pp. 77-278
Closed Access | Times Cited: 275
Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome
Chella Krishna Vadivel, Andreas Willerslev-Olsen, Martin R. J. Namini, et al.
Blood (2024) Vol. 143, Iss. 15, pp. 1496-1512
Open Access | Times Cited: 15
Charting new frontiers: Co-inhibitory immune checkpoint proteins in therapeutics, biomarkers, and drug delivery systems in cancer care
Yao Xiao, Zi‐Zhan Li, Nian‐Nian Zhong, et al.
Translational Oncology (2023) Vol. 38, pp. 101794-101794
Open Access | Times Cited: 16
Real-world study of pegylated interferon α-2a to treat mycosis fungoides/Sézary syndrome using time to next treatment as a measure of clinical benefit: an EORTC CLTG study
Keila Mitsunaga, M. Bagot, C. Ram‐Wolff, et al.
British Journal of Dermatology (2024) Vol. 191, Iss. 3, pp. 419-427
Closed Access | Times Cited: 7
The immune microenviroment in somatotropinomas: from biology to personalized and target therapy
Sabrina Chiloiro, Laura De Marinis
Reviews in Endocrine and Metabolic Disorders (2023) Vol. 24, Iss. 2, pp. 283-295
Open Access | Times Cited: 14
Vitamin D in Cutaneous T-Cell Lymphoma
August-Witte Feentved Ødum, Carsten Geisler
Cells (2024) Vol. 13, Iss. 6, pp. 503-503
Open Access | Times Cited: 5
Pharmacological Modulation of the Unfolded Protein Response as a Therapeutic Approach in Cutaneous T-Cell Lymphoma
N S B Thomas, Benjamin Christopher, Leticia Reyes, et al.
Biomolecules (2025) Vol. 15, Iss. 1, pp. 76-76
Open Access
Construction of a novel radioresistance-related signature for prediction of prognosis, immune microenvironment and anti-tumour drug sensitivity in non-small cell lung cancer
Yanliang Chen, Chan Zhou, Xiaoqiao Zhang, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access
Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review
Lauren Schaefer, Nneka I. Comfere, Olayemi Sokumbi
American Journal of Clinical Dermatology (2023) Vol. 24, Iss. 2, pp. 153-164
Closed Access | Times Cited: 11
The effect of UVA light/8-methoxypsoralen exposure used in Extracorporeal Photopheresis treatment on platelets and extracellular vesicles
Hayley Macleod, Luisa Weiß, Sarah Kelliher, et al.
PLoS ONE (2024) Vol. 19, Iss. 2, pp. e0293687-e0293687
Open Access | Times Cited: 4
Targeting CD47-SIRPα axis for Hodgkin and non-Hodgkin lymphoma immunotherapy
Pengcheng Zhao, Long-Yan Xie, Lei Yu, et al.
Genes & Diseases (2023) Vol. 11, Iss. 1, pp. 205-217
Open Access | Times Cited: 9
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets
Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 584-584
Open Access | Times Cited: 3
Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas
Karol Kołkowski, Magdalena Trzeciak, Małgorzata Sokołowska‐Wojdyło
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13388-13388
Open Access | Times Cited: 20
Broadening the horizon: potential applications of CAR-T cells beyond current indications
Hendrik Karsten, Ludwig Matrisch, Sophia Cichutek, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Immune-related adverse events associated with Mogamulizumab: a comprehensive review of the literature
Genevieve S. Silva, Ellen J. Kim, Stefan K. Barta, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 9, pp. 819-827
Closed Access | Times Cited: 2
Research advances on the immune research and prospect of immunotherapy in pituitary adenomas
Ding Nie, Qiuyue Fang, Bin Li, et al.
World Journal of Surgical Oncology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 17
The Immunotherapeutic Role of Type I and III Interferons in Melanoma and Non-Melanoma Skin Cancers
Sydney Weir, Kailash KC, Shoaib Shoaib, et al.
Life (2023) Vol. 13, Iss. 6, pp. 1310-1310
Open Access | Times Cited: 6
Impact of Mogamulizumab in Real-Life Advanced Cutaneous T-Cell Lymphomas: A Multicentric Retrospective Cohort Study
Marie Jouandet, Inès Nakouri, Lawrence Nadin, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1659-1659
Open Access | Times Cited: 9
Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy
Dana Antonia Țăpoi, Maria-Linda Popa, Cristiana Tănase, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5301-5301
Open Access | Times Cited: 5
Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma
David M. Weiner, Supriya Rastogi, Daniel J. Lewis, et al.
Dermatologic Therapy (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 4
Keratinocytes Present Staphylococcus aureus Enterotoxins and Promote Malignant and Nonmalignant T Cell Proliferation in Cutaneous T-Cell Lymphoma
Ziao Zeng, Chella Krishna Vadivel, Maria Gluud, et al.
Journal of Investigative Dermatology (2024) Vol. 144, Iss. 12, pp. 2789-2804.e10
Open Access | Times Cited: 1
Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients
Hongbin Song, Zhonghui Hu, Shiyu Zhang, et al.
Journal of Dermatological Treatment (2024) Vol. 35, Iss. 1
Open Access | Times Cited: 1
Cutaneous T-cell Lymphoma
David M. Weiner, Alain H. Rook
Hematology/Oncology Clinics of North America (2024) Vol. 38, Iss. 5, pp. 1087-1110
Closed Access | Times Cited: 1
Effects of Extracorporeal Photopheresis on Quality of Life and the Course of Diseases in Patients With Mycosis Fungoides and Graft-Versus-Host Disease: A Single-Center Analysis
Romanos Vogiatzis, William Krüger, Michael Jünger, et al.
Cureus (2023)
Open Access | Times Cited: 3
Causes of Death in Cutaneous T-Cell Lymphoma Patients
Eve Lebas, Patrick Collins, Joan Somja, et al.
Dermatology (2023) Vol. 239, Iss. 6, pp. 860-867
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top